Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Item
http://www.wikidata.org/entity/Q40542672
HbA1c level cannot predict the treatment outcome of smear-positive non-multi-drug-resistant HIV-negative pulmonary tuberculosis inpatients.Tracheobronchial tuberculosisDiabetes and Tuberculosis.Miliary tuberculosis in a patient with tuberculous mycotic aneurysm of the abdominal aorta: Case report and review of the literature.Animal Models for Tuberculosis in Translational and Precision Medicine.Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?Tuberculosis treatment.AJRCCM: 100-Year Anniversary. The History of Official American Thoracic Society Documents.Factors Associated With All-Cause Mortality Among Patients With Multidrug-Resistant Tuberculosis-United States, 1993-2013.Antituberculosis Drug-Induced Adverse Events in the Liver, Kidneys, and Blood: Clinical Profiles and Pharmacogenetic Predictors.Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.Urine IP-10 as a biomarker of therapeutic response in patients with active pulmonary tuberculosis.New and Noteworthy in Tuberculosis Diagnostics and Treatment.Toxicity associated with tuberculosis chemotherapy in the REMoxTB studyChanges in tuberculosis in human immunodeficiency virus infected patients in a Spanish tertiary hospital (1995-2013)
P2860

Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Item
http://www.wikidata.org/entity/Q40542672
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Executive Summary: Official Am ...... Drug-Susceptible Tuberculosis.
@en
type
label
Executive Summary: Official Am ...... Drug-Susceptible Tuberculosis.
@en
prefLabel
Executive Summary: Official Am ...... Drug-Susceptible Tuberculosis.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Executive Summary: Official Am ...... Drug-Susceptible Tuberculosis
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932